Cynosure Gets the Street's Attention
Can Cynosure (CYNO) manage to profit from its services for people who want to turn back the efects of time on their faces and bodies? Mark Richter, an analyst at Jefferies & Co., is expecting to see the Westford (Mass.) company's sales grow. He said in a Mar. 28 report that the medical and cosmetic device maker's stock price will likely rise to $34 per share, after he'd predicted $30 earlier. Investors bid up the stock 7.8% to $29.07 per share on Mar. 28.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.